Skip to main content
Biotech & Health Tech

How Hims plans to revive its business after pivoting to branded GLP-1s

Endpoints News (Biopharma) · Nov 12, 2026 — 02:20 · 1 views · Original article ↗

Hims & Hers, once obsessed with delivering "personalized care" through compounded drug products, is now banking on brand-name treatments and the pharmaceutical giants it previously tried to undercut. Hims struck a deal with Eli Lilly ...

Hims & Hers, once obsessed with delivering "personalized care" through compounded drug products, is now banking on brand-name treatments and the pharmaceutical giants it previously tried to undercut. Hims struck a deal with Eli Lilly ...

This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗

Ready to grow your traffic?

Run a free SEO audit of your website in under 60 seconds — no account required.

Get Your Free SEO Audit Explore Our Services